CCL2 and atherosclerosis: Both Ccr2 and Ccl2 knockout in atherosclerosis-prone mice (178, 179) as well as Ccr2 targeted siRNA treatment (180) significantly reduced atherosclerotic plaque formation, whereas in contrast, leukocyte-specific overexpression of Ccl2 in Apoe−/− mice promoted atherosclerosis progression (181).